1 Study Coverage 1.1 Kidney Disease Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Kidney Disease Drugs Market Size Growth Rate by Type 1.2.2 Tablets 1.2.3 Capsule 1.2.4 Other 1.3 Market by Application 1.3.1 Global Kidney Disease Drugs Market Size Growth Rate by Application 1.3.2 Chronic Glomerulonephritis 1.3.3 Nephrotic Syndrome 1.3.4 Chronic Renal Failure 1.3.5 Kidney Stones 1.3.6 Renal Cyst (polycystic Kidney) 1.3.7 Diabetic Nephropathy 1.3.8 Hypertensive Nephropathy 1.3.9 Purpura Nephritis 1.3.10 Lupus Nephritis 1.3.11 Pediatric Kidney Disease 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Kidney Disease Drugs Market Size, Estimates and Forecasts 2.1.1 Global Kidney Disease Drugs Revenue 2016-2027 2.1.2 Global Kidney Disease Drugs Sales 2016-2027 2.2 Global Kidney Disease Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Kidney Disease Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Kidney Disease Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Kidney Disease Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027) 3 Global Kidney Disease Drugs Competitor Landscape by Players 3.1 Global Top Kidney Disease Drugs Manufacturers by Sales 3.1.1 Global Kidney Disease Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Kidney Disease Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Kidney Disease Drugs Manufacturers by Revenue 3.2.1 Key Kidney Disease Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Kidney Disease Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Kidney Disease Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Kidney Disease Drugs Revenue in 2020 3.2.6 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Kidney Disease Drugs Price by Manufacturers 3.4 Global Kidney Disease Drugs Manufacturing Base Distribution, Product Types 3.4.1 Kidney Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Kidney Disease Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Kidney Disease Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Kidney Disease Drugs Market Size by Type (2016-2021) 4.1.1 Global Kidney Disease Drugs Sales by Type (2016-2021) 4.1.2 Global Kidney Disease Drugs Revenue by Type (2016-2021) 4.1.3 Kidney Disease Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Kidney Disease Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Kidney Disease Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Kidney Disease Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Kidney Disease Drugs Market Size by Application (2016-2021) 5.1.1 Global Kidney Disease Drugs Sales by Application (2016-2021) 5.1.2 Global Kidney Disease Drugs Revenue by Application (2016-2021) 5.1.3 Kidney Disease Drugs Price by Application (2016-2021) 5.2 Kidney Disease Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Kidney Disease Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Kidney Disease Drugs Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Kidney Disease Drugs Market Size YoY Growth 2016-2027 6.1.1 China Kidney Disease Drugs Sales YoY Growth 2016-2027 6.1.2 China Kidney Disease Drugs Revenue YoY Growth 2016-2027 6.1.3 China Kidney Disease Drugs Market Share in Global Market 2016-2027 6.2 China Kidney Disease Drugs Market Size by Players (International and Local Players) 6.2.1 China Top Kidney Disease Drugs Players by Sales (2016-2021) 6.2.2 China Top Kidney Disease Drugs Players by Revenue (2016-2021) 6.3 China Kidney Disease Drugs Historic Market Review by Type (2016-2021) 6.3.1 China Kidney Disease Drugs Sales Market Share by Type (2016-2021) 6.3.2 China Kidney Disease Drugs Revenue Market Share by Type (2016-2021) 6.3.3 China Kidney Disease Drugs Price by Type (2016-2021) 6.4 China Kidney Disease Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Kidney Disease Drugs Sales Forecast by Type (2022-2027) 6.4.2 China Kidney Disease Drugs Revenue Forecast by Type (2022-2027) 6.4.3 China Kidney Disease Drugs Price Forecast by Type (2022-2027) 6.5 China Kidney Disease Drugs Historic Market Review by Application (2016-2021) 6.5.1 China Kidney Disease Drugs Sales Market Share by Application (2016-2021) 6.5.2 China Kidney Disease Drugs Revenue Market Share by Application (2016-2021) 6.5.3 China Kidney Disease Drugs Price by Application (2016-2021) 6.6 China Kidney Disease Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Kidney Disease Drugs Sales Forecast by Application (2022-2027) 6.6.2 China Kidney Disease Drugs Revenue Forecast by Application (2022-2027) 6.6.3 China Kidney Disease Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Kidney Disease Drugs Market Size YoY Growth 2016-2027 7.2 North America Kidney Disease Drugs Market Facts & Figures by Country 7.2.1 North America Kidney Disease Drugs Sales by Country (2016-2021) 7.2.2 North America Kidney Disease Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Kidney Disease Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Kidney Disease Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Kidney Disease Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Kidney Disease Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Kidney Disease Drugs Market Size YoY Growth 2016-2027 9.2 Europe Kidney Disease Drugs Market Facts & Figures by Country 9.2.1 Europe Kidney Disease Drugs Sales by Country (2016-2021) 9.2.2 Europe Kidney Disease Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Kidney Disease Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Kidney Disease Drugs Market Facts & Figures by Country 10.2.1 Latin America Kidney Disease Drugs Sales by Country (2016-2021) 10.2.2 Latin America Kidney Disease Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Kidney Disease Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Kidney Disease Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Kidney Disease Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Kidney Disease Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Description and Business Overview 12.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GlaxoSmithKline Kidney Disease Drugs Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Sanofi 12.2.1 Sanofi Corporation Information 12.2.2 Sanofi Description and Business Overview 12.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sanofi Kidney Disease Drugs Products Offered 12.2.5 Sanofi Recent Development 12.3 Roche 12.3.1 Roche Corporation Information 12.3.2 Roche Description and Business Overview 12.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Roche Kidney Disease Drugs Products Offered 12.3.5 Roche Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Description and Business Overview 12.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Kidney Disease Drugs Products Offered 12.4.5 Pfizer Recent Development 12.5 AstraZeneca 12.5.1 AstraZeneca Corporation Information 12.5.2 AstraZeneca Description and Business Overview 12.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 AstraZeneca Kidney Disease Drugs Products Offered 12.5.5 AstraZeneca Recent Development 12.6 Keryx Biopharmaceuticals 12.6.1 Keryx Biopharmaceuticals Corporation Information 12.6.2 Keryx Biopharmaceuticals Description and Business Overview 12.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Products Offered 12.6.5 Keryx Biopharmaceuticals Recent Development 12.7 Kissei Pharmaceutical 12.7.1 Kissei Pharmaceutical Corporation Information 12.7.2 Kissei Pharmaceutical Description and Business Overview 12.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Kissei Pharmaceutical Kidney Disease Drugs Products Offered 12.7.5 Kissei Pharmaceutical Recent Development 12.8 AbbVie 12.8.1 AbbVie Corporation Information 12.8.2 AbbVie Description and Business Overview 12.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 AbbVie Kidney Disease Drugs Products Offered 12.8.5 AbbVie Recent Development 12.9 Amgen 12.9.1 Amgen Corporation Information 12.9.2 Amgen Description and Business Overview 12.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Amgen Kidney Disease Drugs Products Offered 12.9.5 Amgen Recent Development 12.10 Teva Pharmaceutical Industries 12.10.1 Teva Pharmaceutical Industries Corporation Information 12.10.2 Teva Pharmaceutical Industries Description and Business Overview 12.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Products Offered 12.10.5 Teva Pharmaceutical Industries Recent Development 12.11 GlaxoSmithKline 12.11.1 GlaxoSmithKline Corporation Information 12.11.2 GlaxoSmithKline Description and Business Overview 12.11.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GlaxoSmithKline Kidney Disease Drugs Products Offered 12.11.5 GlaxoSmithKline Recent Development 12.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical 12.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information 12.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview 12.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Products Offered 12.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development 12.13 Datong Liqun Pharmaceutical 12.13.1 Datong Liqun Pharmaceutical Corporation Information 12.13.2 Datong Liqun Pharmaceutical Description and Business Overview 12.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Datong Liqun Pharmaceutical Products Offered 12.13.5 Datong Liqun Pharmaceutical Recent Development 12.14 Hebei Ruisen Pharmaceutical 12.14.1 Hebei Ruisen Pharmaceutical Corporation Information 12.14.2 Hebei Ruisen Pharmaceutical Description and Business Overview 12.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Hebei Ruisen Pharmaceutical Products Offered 12.14.5 Hebei Ruisen Pharmaceutical Recent Development 12.15 Changxing Pharmaceutical 12.15.1 Changxing Pharmaceutical Corporation Information 12.15.2 Changxing Pharmaceutical Description and Business Overview 12.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Changxing Pharmaceutical Products Offered 12.15.5 Changxing Pharmaceutical Recent Development 12.16 zhejiang Shengbokang Pharmaceutical 12.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information 12.16.2 zhejiang Shengbokang Pharmaceutical Description and Business Overview 12.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 12.16.4 zhejiang Shengbokang Pharmaceutical Products Offered 12.16.5 zhejiang Shengbokang Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Kidney Disease Drugs Industry Trends 13.2 Kidney Disease Drugs Market Drivers 13.3 Kidney Disease Drugs Market Challenges 13.4 Kidney Disease Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Kidney Disease Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Kidney Disease Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Tablets Table 3. Major Manufacturers of Capsule Table 4. Major Manufacturers of Other Table 5. Global Kidney Disease Drugs Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Kidney Disease Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Kidney Disease Drugs Sales by Regions (2016-2021) & (K Units) Table 8. Global Kidney Disease Drugs Sales Market Share by Regions (2016-2021) Table 9. Global Kidney Disease Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Kidney Disease Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Kidney Disease Drugs Sales Market Share Forecast by Region (2022-2027) Table 12. Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Kidney Disease Drugs Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Kidney Disease Drugs Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Kidney Disease Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 17. Kidney Disease Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Kidney Disease Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Global Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Disease Drugs as of 2020) Table 21. Key Manufacturers Kidney Disease Drugs Price (2016-2021) (US$/Unit) Table 22. Kidney Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Kidney Disease Drugs Product Type Table 24. Date of International Manufacturers Enter into Kidney Disease Drugs Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Kidney Disease Drugs Sales by Type (2016-2021) (K Units) Table 27. Global Kidney Disease Drugs Sales Share by Type (2016-2021) Table 28. Global Kidney Disease Drugs Revenue by Type (2016-2021) (US$ Million) Table 29. Global Kidney Disease Drugs Revenue Share by Type (2016-2021) Table 30. Kidney Disease Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Kidney Disease Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2022-2027) Table 33. Global Kidney Disease Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Kidney Disease Drugs Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Kidney Disease Drugs Sales by Application (2016-2021) (K Units) Table 37. Global Kidney Disease Drugs Sales Share by Application (2016-2021) Table 38. Global Kidney Disease Drugs Revenue by Application (2016-2021) (US$ Million) Table 39. Global Kidney Disease Drugs Revenue Share by Application (2016-2021) Table 40. Kidney Disease Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Kidney Disease Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Kidney Disease Drugs Sales Market Share Forecast by Application (2022-2027) Table 43. Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Kidney Disease Drugs Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Kidney Disease Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Kidney Disease Drugs Sales (K Units) of Key Companies (2016-2021) Table 47. China Kidney Disease Drugs Sales Share by Company (2016-2021) Table 48. China Kidney Disease Drugs Revenue (US$ Million) by Company (2016-2021) Table 49. China Kidney Disease Drugs Revenue Share by Company (2016-2021) Table 50. China Kidney Disease Drugs Sales (K Units) by Type (2016-2021) Table 51. China Kidney Disease Drugs Sales Share by Type (2016-2021) Table 52. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Kidney Disease Drugs Price (US$/Unit) by Type (2016-2021) Table 54. China Kidney Disease Drugs Sales (K Units) by Type (2022-2027) Table 55. China Kidney Disease Drugs Sales Share by Type (2022-2027) Table 56. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Kidney Disease Drugs Revenue Share by Type (2022-2027) Table 58. China Kidney Disease Drugs Price (US$/Unit) by Type (2022-2027) Table 59. China Kidney Disease Drugs Sales (K Units) by Application (2016-2021) Table 60. China Kidney Disease Drugs Sales Share by Application (2016-2021) Table 61. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Kidney Disease Drugs Price (US$/Unit) by Application (2016-2021) Table 63. China Kidney Disease Drugs Sales (K Units) by Application (2022-2027) Table 64. China Kidney Disease Drugs Sales Share by Application (2022-2027) Table 65. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Kidney Disease Drugs Revenue Share by Application (2022-2027) Table 67. China Kidney Disease Drugs Price (US$/Unit) by Application (2022-2027) Table 68. North America Kidney Disease Drugs Sales by Country (2016-2021) & (K Units) Table 69. North America Kidney Disease Drugs Sales Market Share by Country (2016-2021) Table 70. North America Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Kidney Disease Drugs Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Kidney Disease Drugs Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Kidney Disease Drugs Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Kidney Disease Drugs Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region (2016-2021) Table 76. Europe Kidney Disease Drugs Sales by Country (2016-2021) & (K Units) Table 77. Europe Kidney Disease Drugs Sales Market Share by Country (2016-2021) Table 78. Europe Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Kidney Disease Drugs Revenue Market Share by Country (2016-2021) Table 80. Latin America Kidney Disease Drugs Sales by Country (2016-2021) & (K Units) Table 81. Latin America Kidney Disease Drugs Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Kidney Disease Drugs Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Kidney Disease Drugs Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country (2016-2021) Table 88. GlaxoSmithKline Corporation Information Table 89. GlaxoSmithKline Description and Business Overview Table 90. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. GlaxoSmithKline Kidney Disease Drugs Product Table 92. GlaxoSmithKline Recent Development Table 93. Sanofi Corporation Information Table 94. Sanofi Description and Business Overview Table 95. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Sanofi Product Table 97. Sanofi Recent Development Table 98. Roche Corporation Information Table 99. Roche Description and Business Overview Table 100. Roche Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Roche Product Table 102. Roche Recent Development Table 103. Pfizer Corporation Information Table 104. Pfizer Description and Business Overview Table 105. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Pfizer Product Table 107. Pfizer Recent Development Table 108. AstraZeneca Corporation Information Table 109. AstraZeneca Description and Business Overview Table 110. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. AstraZeneca Product Table 112. AstraZeneca Recent Development Table 113. Keryx Biopharmaceuticals Corporation Information Table 114. Keryx Biopharmaceuticals Description and Business Overview Table 115. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Keryx Biopharmaceuticals Product Table 117. Keryx Biopharmaceuticals Recent Development Table 118. Kissei Pharmaceutical Corporation Information Table 119. Kissei Pharmaceutical Description and Business Overview Table 120. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Kissei Pharmaceutical Product Table 122. Kissei Pharmaceutical Recent Development Table 123. AbbVie Corporation Information Table 124. AbbVie Description and Business Overview Table 125. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. AbbVie Product Table 127. AbbVie Recent Development Table 128. Amgen Corporation Information Table 129. Amgen Description and Business Overview Table 130. Amgen Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Amgen Product Table 132. Amgen Recent Development Table 133. Teva Pharmaceutical Industries Corporation Information Table 134. Teva Pharmaceutical Industries Description and Business Overview Table 135. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Teva Pharmaceutical Industries Product Table 137. Teva Pharmaceutical Industries Recent Development Table 138. Tianjin Tongrentang Group Corporation Information Table 139. Tianjin Tongrentang Group Description and Business Overview Table 140. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Tianjin Tongrentang Group Product Table 142. Tianjin Tongrentang Group Recent Development Table 143. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information Table 144. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview Table 145. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Product Table 147. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development Table 148. Datong Liqun Pharmaceutical Corporation Information Table 149. Datong Liqun Pharmaceutical Description and Business Overview Table 150. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Datong Liqun Pharmaceutical Product Table 152. Datong Liqun Pharmaceutical Recent Development Table 153. Hebei Ruisen Pharmaceutical Corporation Information Table 154. Hebei Ruisen Pharmaceutical Description and Business Overview Table 155. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Hebei Ruisen Pharmaceutical Product Table 157. Hebei Ruisen Pharmaceutical Recent Development Table 158. Changxing Pharmaceutical Corporation Information Table 159. Changxing Pharmaceutical Description and Business Overview Table 160. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. Changxing Pharmaceutical Product Table 162. Changxing Pharmaceutical Recent Development Table 163. zhejiang Shengbokang Pharmaceutical Corporation Information Table 164. zhejiang Shengbokang Pharmaceutical Description and Business Overview Table 165. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. zhejiang Shengbokang Pharmaceutical Product Table 167. zhejiang Shengbokang Pharmaceutical Recent Development Table 168. Kidney Disease Drugs Market Trends Table 169. Kidney Disease Drugs Market Drivers Table 170. Kidney Disease Drugs Market Challenges Table 171. Kidney Disease Drugs Market Restraints Table 172. Kidney Disease Drugs Customers List Table 173. Kidney Disease Drugs Distributors List Table 174. Research Programs/Design for This Report Table 175. Key Data Information from Secondary Sources Table 176. Key Data Information from Primary Sources List of Figures Figure 1. Kidney Disease Drugs Product Picture Figure 2. Global Kidney Disease Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Capsule Product Picture Figure 5. Other Product Picture Figure 6. Global Kidney Disease Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Chronic Glomerulonephritis Figure 8. Nephrotic Syndrome Figure 9. Chronic Renal Failure Figure 10. Kidney Stones Figure 11. Renal Cyst (polycystic Kidney) Figure 12. Diabetic Nephropathy Figure 13. Hypertensive Nephropathy Figure 14. Purpura Nephritis Figure 15. Lupus Nephritis Figure 16. Pediatric Kidney Disease Figure 17. Kidney Disease Drugs Report Years Considered Figure 18. Global Kidney Disease Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Kidney Disease Drugs Market Size 2016-2027 (US$ Million) Figure 20. Global Kidney Disease Drugs Sales 2016-2027 (K Units) Figure 21. Global Kidney Disease Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 22. Global Kidney Disease Drugs Sales Market Share by Region (2016-2021) Figure 23. Global Kidney Disease Drugs Sales Market Share by Region in 2020 Figure 24. Global Kidney Disease Drugs Revenue Market Share by Region (2016-2021) Figure 25. Global Kidney Disease Drugs Revenue Market Share by Region in 2020 Figure 26. Global Kidney Disease Drugs Sales Share by Manufacturer in 2020 Figure 27. The Top 10 and 5 Players Market Share by Kidney Disease Drugs Revenue in 2020 Figure 28. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Kidney Disease Drugs Sales Market Share by Type (2016-2021) Figure 30. Global Kidney Disease Drugs Sales Market Share by Type in 2020 Figure 31. Global Kidney Disease Drugs Revenue Market Share by Type (2016-2021) Figure 32. Global Kidney Disease Drugs Revenue Market Share by Type in 2020 Figure 33. Global Kidney Disease Drugs Sales Market Share by Application (2016-2021) Figure 34. Global Kidney Disease Drugs Sales Market Share by Application in 2020 Figure 35. Global Kidney Disease Drugs Revenue Market Share by Application (2016-2021) Figure 36. Global Kidney Disease Drugs Revenue Market Share by Application in 2020 Figure 37. China Kidney Disease Drugs Sales Growth Rate 2016-2027 (K Units) Figure 38. China Kidney Disease Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 39. China Kidney Disease Drugs Market Share in Global Market 2016-2027 Figure 40. China 5 and 10 Largest Kidney Disease Drugs Players Market Share by Revenue in Kidney Disease Drugs in 2020 Figure 41. China Kidney Disease Drugs Revenue Share by Type (2016-2021) Figure 42. China Kidney Disease Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 43. China Kidney Disease Drugs Revenue Share by Application (2016-2021) Figure 44. China Kidney Disease Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 45. North America Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units) Figure 46. North America Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. North America Kidney Disease Drugs Sales Market Share by Country in 2020 Figure 48. North America Kidney Disease Drugs Revenue Market Share by Country in 2020 Figure 49. U.S. Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 50. U.S. Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Canada Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 52. Canada Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. Europe Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units) Figure 54. Europe Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 55. Europe Kidney Disease Drugs Sales Market Share by Country in 2020 Figure 56. Europe Kidney Disease Drugs Revenue Market Share by Country in 2020 Figure 57. Germany Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 58. Germany Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. France Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 60. France Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. U.K. Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 62. U.K. Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Italy Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 64. Italy Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Russia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 66. Russia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Asia Pacific Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units) Figure 68. Asia Pacific Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 69. Asia Pacific Kidney Disease Drugs Sales Market Share by Region in 2020 Figure 70. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region in 2020 Figure 71. China Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 72. China Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Japan Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 74. Japan Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. South Korea Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 76. South Korea Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. India Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 78. India Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Australia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 80. Australia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Taiwan Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 82. Taiwan Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Indonesia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 84. Indonesia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Thailand Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 86. Thailand Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Malaysia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 88. Malaysia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Philippines Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 90. Philippines Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Vietnam Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 92. Vietnam Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Latin America Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units) Figure 94. Latin America Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 95. Latin America Kidney Disease Drugs Sales Market Share by Country in 2020 Figure 96. Latin America Kidney Disease Drugs Revenue Market Share by Country in 2020 Figure 97. Mexico Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 98. Mexico Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Brazil Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 100. Brazil Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Argentina Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 102. Argentina Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Middle East and Africa Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units) Figure 104. Middle East and Africa Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 105. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country in 2020 Figure 106. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country in 2020 Figure 107. Turkey Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 108. Turkey Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. Saudi Arabia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 110. Saudi Arabia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 111. UAE Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units) Figure 112. UAE Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 113. Kidney Disease Drugs Value Chain Figure 114. Channels of Distribution Figure 115. Distributors Profiles Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

GlaxoSmithKline Sanofi Roche Pfizer AstraZeneca Keryx Biopharmaceuticals Kissei Pharmaceutical AbbVie Amgen Teva Pharmaceutical Industries Tianjin Tongrentang Group Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Datong Liqun Pharmaceutical Hebei Ruisen Pharmaceutical Changxing Pharmaceutical zhejiang Shengbokang Pharmaceutical